We are live on ! Find out more
SIC

SJS Investment Consulting Portfolio holdings

AUM $919M
1-Year Est. Return 23.4%
This Fund
S&P 500
This Quarter Est. Return
+3.48%
1 Year Est. Return
+23.4%
3 Year Est. Return
+63.82%
5 Year Est. Return
10 Year Est. Return
AUM
$790M
AUM Growth
+$59.5M
Cap. Flow
+$38M
Cap. Flow %
4.8%
Top 10 Hldgs %
74.43%
Holding
2,160
New
526
Increased
829
Reduced
265
Closed
73

Sector Composition

Rank Sector Weight
1 Technology 5.65%
2 Healthcare 3.61%
3 Consumer Staples 2.82%
4 Financials 2.32%
5 Communication Services 1.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PODD icon
676
Insulet
PODD
$10B
$16.8K ﹤0.01%
59
+57
+2,850% +$17.8K
GDDY icon
677
GoDaddy
GDDY
$11.5B
$16.8K ﹤0.01%
135
+125
+1,250% +$16.2K
NCLH icon
678
Norwegian Cruise Line
NCLH
$8.59B
$16.7K ﹤0.01%
746
+712
+2,094% +$15K
ETSY icon
679
Etsy
ETSY
$7.29B
$16.5K ﹤0.01%
297
-465
-61% -$28.4K
NVO
680
Novo Nordisk
NVO
$207B
$16.3K ﹤0.01%
321
+171
+114% +$8.74K
TMHC
681
DELISTED
Taylor Morrison
TMHC
$16.3K ﹤0.01%
277
+258
+1,358% +$15.8K
PRU icon
682
Prudential Financial
PRU
$42.2B
$16.3K ﹤0.01%
144
+28
+24% +$3K
SEIC icon
683
SEI Investments
SEIC
$12.6B
$16.2K ﹤0.01%
198
-159
-45% -$13.1K
SITE icon
684
SiteOne Landscape Supply
SITE
$4.32B
$16.2K ﹤0.01%
130
+127
+4,233% +$16.1K
DLN icon
685
WisdomTree US LargeCap Dividend Fund
DLN
$6.4B
$16K ﹤0.01%
182
HMC icon
686
Honda
HMC
$41.1B
$16K ﹤0.01%
543
+343
+172% +$10.4K
PCTY icon
687
Paylocity
PCTY
$7.7B
$15.9K ﹤0.01%
104
-194
-65% -$28.9K
CHTR icon
688
Charter Communications
CHTR
$18.8B
$15.7K ﹤0.01%
+75
New +$16.9K
ARKG icon
689
ARK Genomic Revolution ETF
ARKG
$1.79B
$15.6K ﹤0.01%
538
AR icon
690
Antero Resources
AR
$11.6B
$15.5K ﹤0.01%
451
+413
+1,087% +$14K
MRVL icon
691
Marvell Technology
MRVL
$191B
$15.4K ﹤0.01%
181
+158
+687% +$13.8K
ARQT icon
692
Arcutis Biotherapeutics
ARQT
$3.3B
$15.4K ﹤0.01%
529
+391
+283% +$10K
EXAS
693
DELISTED
Exact Sciences
EXAS
$15.3K ﹤0.01%
151
+148
+4,933% +$11.9K
NOVT icon
694
Novanta
NOVT
$6.34B
$15.1K ﹤0.01%
+127
New +$14.5K
TAK icon
695
Takeda Pharmaceutical
TAK
$55.8B
$15K ﹤0.01%
+961
New +$13.7K
EQT icon
696
EQT Corp
EQT
$34B
$14.8K ﹤0.01%
276
+245
+790% +$13.8K
FNDF icon
697
Schwab Fundamental International Large Company Index ETF
FNDF
$25.6B
$14.6K ﹤0.01%
323
DFEB icon
698
FT Vest US Equity Deep Buffer ETF February
DFEB
$463M
$14.6K ﹤0.01%
305
OSCR icon
699
Oscar Health
OSCR
$8.63B
$14.5K ﹤0.01%
1,011
+1,000
+9,091% +$17.3K
VMI icon
700
Valmont Industries
VMI
$9.52B
$14.5K ﹤0.01%
36
+16
+80% +$6.51K

Similar funds

SJS Investment Consulting's Q4 2025 Portfolio in Review

As of Q4 2025, SJS Investment Consulting held 2,160 positions worth $790M, up 8.1% from $731M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

SJS Investment Consulting deployed $38M of net new capital in Q4 2025, opening 526 new positions and adding to 829 existing holdings. Its largest new stake was State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF: 829 shares worth $68.4K.

By sector, the portfolio is most concentrated in Technology at 5.6% of assets, up from 5.4% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Grayscale Bitcoin Mini Trust ETF, an estimated $873K trimmed.

  • SJS Investment Consulting's largest Q4 2025 buy was State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF: 829 shares worth $68.4K.
  • SJS Investment Consulting added most to Vanguard 0-3 Month Treasury Bill ETF in Q4 2025, an estimated $6.39M increase.
  • SJS Investment Consulting's biggest Q4 2025 reduction was Grayscale Bitcoin Mini Trust ETF, cutting an estimated $873K.
  • SJS Investment Consulting fully exited Olin in Q4 2025, selling an estimated $49.1K.
  • SJS Investment Consulting's ten largest holdings make up 74% of its $790M portfolio in Q4 2025.
  • SJS Investment Consulting opened 526 new positions and closed 73 in Q4 2025.
  • SJS Investment Consulting's portfolio value rose 8.1% quarter-over-quarter to $790M.

Based on SJS Investment Consulting's 13F filing for Q4 2025, filed 21 Jan 2026.